BTSG vs GRDN
BTSG: An integrated, national home-based care provider delivering complementary pharmacy and clinical services to medically complex patients to reduce hospitalizations and lower costs. GRDN: Guardian is a specialized pharmacy services provider delivering high-touch clinical and dispensing solutions to long-term care facilities, particularly assisted living and behavioral health settings, to improve medication adherence and reduce healthcare costs.
Side-by-side fundamentals
| Metric | BTSG | GRDN | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $69.74 | $39.77 | |
| Market cap as of 2026-07-23 | $13.7B | $2.6B | |
| P/E as of 2026-07-23 | 44.17 | 48.45 | BTSG lower |
| PEG as of 2026-07-23 | 1.97 | n/a | |
| Net margin as of 2026-07-23 | +2.3% | +3.6% | GRDN higher |
| Gross margin as of 2026-07-23 | +12.2% | +20.9% | GRDN higher |
| Operating margin as of 2026-07-23 | +2.7% | +5.3% | GRDN higher |
| ROE as of 2026-07-23 | +16.7% | +27.2% | GRDN higher |
| ROA as of 2026-07-23 | +5.0% | +13.4% | GRDN higher |
| Debt / equity as of 2026-07-23 | 1.27 | 0.00 | GRDN lower |
| Revenue growth (YoY) as of 2026-07-23 | +18.0% | +11.3% | BTSG higher |
| Revenue CAGR (3y) SEC XBRL | +18.7% | n/a | |
| Beta as of 2026-07-23 | 1.84 | 0.35 | |
| 1-year return as of 2026-07-22 close | +246.1% | +95.8% | BTSG higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.